Lyndra Therapeutics and Gilead Sciences to collaborate on development of ultra-long-acting HIV therapeutics

Image: Lyndra Therapeutics and Gilead Sciences to collaborate on development of ultra-long-acting HIV therapeutics. Photo: courtesy of Adam Radosavljevic from Pixabay.